Mayne Pharma | MYX - Eigenkapital Und Reserven

Aktienkurs
2.13
Täglich Wechseln
-0.19 -8.19%
Monatlich
-19.62%
Jährlich
-70.54%
Q1 Prognose
2.33




Eigenkapital Und Reserven Veränderung Datum
Ansell USD 1.97B 10.2M 2025-12
Avita Medical AUD -16.65M 3.76M 2025-12
Cochlear AUD 1.94B 12.2M 2025-12
CSL USD 18.66B 2.75B 2025-12
Healius AUD 1.03B 13.9M 2024-12
Integral Diagnostics AUD 301.71M 1.33M 2024-06
Medical Developments International AUD 54.77M 335K 2025-12
Nanosonics AUD 219.69M 9.78M 2025-12
Polynovo AUD 72.12M 3.07M 2024-06
Ramsay Health Care AUD 4.79B 916.1M 2025-12
ResMed USD 6.32B 199.62M 2025-12
Sigma Healthcare AUD 4.67B 3.8B 2025-12
Sonic Healthcare AUD 8.2B 120.9M 2024-12
Telix Pharmaceuticals AUD 416.86M 5.08M 2025-12